It can be challenging to keep up with patient resources and research developments. Our Town Hall presentations can help you as you work with your doctor to manage your care for kidney cancer. Click the event links to view the page resources and webinar videos.
In this Town Hall, Dr. Naomi Haas, University of Pennsylvania, looked back at key advances and lessons from 2025. Dr. Daniel George, Duke University, looked forward at emerging science, trials, and practice-changing questions for 2026.
Oncology Nurses play a key role in kidney cancer treatment, often serving as the frontline providers who guide patients through side effect management. The webinar topics included managing treatment-related side effects, care coordination and self-advocacy.
A panel of patients shared practical advice, emotional insights, and strategies for navigating diagnosis, treatment, and survivorship. Moderated by Dr. Moshe Ornstein, this session offered essential guidance and connection for patients, caregivers, and advocates.
Renowned clinical kidney cancer researchers Dr. Sumanta Pal and Dr. Laurence Albiges presented a retrospective of 2024 research breakthroughs, along with a look forward at what we can expect in 2025.
Kidney cancer patients and leading researchers united to illuminate the clinical trials journey. Discover firsthand experiences, unlock vital communication strategies, and explore the latest trials shaping the future of kidney cancer treatment.
Listen as three patients diagnosed with kidney cancer reflect on their diagnosis, living fully with kidney cancer, getting support, and making the most of their time. A conversation for patients and caregivers.
Renowned clinical kidney cancer researchers shared a retrospective of 2022 breakthroughs, along with a look forward at what we can expect in 2023, at our recent Town Hall event.
Learn the basics of the clinical trial process and why trial participation can make sense anywhere along your treatment journey. Consents, endpoints, patient rights, and how trial participation affects clinical care.
Our expert panel of oncologists discussed how they shared the immunotherapy treatment decision-making process with their patients. How these experts take your health, kidney cancer subtype and preferences into account when they suggest options for your immunotherapy treatments.
Join Us!
Error: No connected account.
Please go to the Instagram Feed settings page to connect an account.
